NASDAQ
8.19USD
-0.34 (-3.99%)
We have scored 4 news catalysts on SOPHiA GENETICS S.A. (SOPH) over the past 12 months. The biggest single-day move next to one of them came Aug 4, 2026, when SOPH closed +20.2%: “SOPHiA GENETICS Reports Second Quarter 2026 Results”. Coverage across the window leans positive (average ticker sentiment +0.60). Most of the impact sits in forward growth expectations and revenue growth rate.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
687.1M
P/E
—
EPS
—
Beta
0.98
52W range
3.15-8.98
Day range
8.12–8.70
Open
8.56
Prev close
8.53
Volume
964.2K
Avg volume
397.5K
Dividend
0.00
IPO
2021-07-23
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about SOPHiA GENETICS S.A. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for SOPH: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
